Looking for the new Ozempic? Say hello to peptide therapy

By now we've all heard of Ozempic and its GLP-1 sisters Wegovy and Mounjaro. But what you might not know is that they are part of a broader family of molecules called peptides, which the most cutting-edge doctors are using for potentially life-changing preventative therapies.

- Jessica Salter

Dr Mohammed Enayat, an east London GP and founder of longevity clinic HUM2N, believes they could be the secret to longer, healthier lives, with newer peptide therapies being used to tackle conditions including brain-related diseases such as Parkinson's and Alzheimer's, cardiometabolic disease, which includes obesity and type 2 diabetes, along with cardiovascular complications such as heart disease and stroke.

Enayat, who trained for a period in a Californian stem cell research laboratory, first heard about “peptides being used in longevity practice around three years ago from US colleagues”. He now offers peptides as longevity treatments for his patients at HUM2N. “I find them really exciting,” he says. “In the right hands, for the right patients, they can be really effective as preventative treatment and promoting longevity.”